Clinical tuberculosis

Medicine

Volumn 36, Issue 6, 2008, Pages 300-305

  Barker, Richard D ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

acquired immunodeficiency syndrome; central nervous system; HIV; meningeal; multidrug resistant; tuberculosis

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; COTRIMOXAZOLE; DEXAMETHASONE; ETHAMBUTOL; ISONIAZID; PROTEINASE INHIBITOR; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; RIFAMPICIN; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TUBERCULOSTATIC AGENT;

AFRICA; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; CERVICAL LYMPH NODE; CLINICAL FEATURE; DIAGNOSTIC TEST; DIRECTLY OBSERVED THERAPY; EPIDEMIC; EXTRAPULMONARY TUBERCULOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LUNG DISEASE; LUNG TUBERCULOSIS; MEDICAL ASSESSMENT; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SHORT COURSE THERAPY; TUBERCULOSIS; TUBERCULOUS PLEURISY; TUBERCULOUS SPONDYLITIS; UNITED KINGDOM; WESTERN EUROPE;

EID: 44249101646     PISSN: 13573039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpmed.2008.03.008     Document Type: Review

References (28)

1. Dye C. Global epidemiology of tuberculosis. Lancet 367 (2006) 938-940
2. Rose A.M.C., Watson J.M., Graham C., et al. Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998. Thorax 56 (2001) 173-179
3. Maguire H., Dale J.W., McHugh T.D., et al. Molecular epidemiology of tuberculosis in London 1995-7 showing low rate of active transmission. Thorax 57 (2002) 617-622
4. Story A., Murad S., Verheyen M., Roberts W., and Hayward A.C. Tuberculosis in London - the importance of homelessness, problem drug use and prison. Thorax 62 (2007) 667-671
5. Geng E., Kreiswirth B., Driver C., et al. Changes in the transmission of tuberculosis in New York City from 1990 to 1999. N Engl J Med 346 (2002) 1453-1458
6. Djuretic T., Herbert J., Drobniewski F., et al. Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999. Thorax 57 (2002) 477-482
7. Ruddy M.C., Davies A.P., Yates M.D., et al. Outbreak of isoniazid resistant tuberculosis in north London. Thorax 59 (2004) 279-285
8. Gandhi N.R., Moll A., Sturm A.W., et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368 (2006) 1575-1580
9. Aziz M.A., Wright A., Laszlo A., et al. Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis. Lancet 368 (2006) 2142-2154
10. Horsburgh Jr. C.R. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 350 (2004) 2060-2067
11. International Union Against Tuberculosis and Lung Disease. Sputum examination for tuberculosis by direct microscopy in low income countries. Paris (2000).
12. Khan M.S., Dar O., Sismanidis C., Shah K., and Godfrey-Faussett P. Improvement of tuberculosis case detection and reduction of discrepancies between men and women by simple sputum-submission instructions: a pragmatic randomised controlled trial. Lancet 369 (2007) 1955-1960
13. van Cleeff M.R., Kivihya-Ndugga L., Githui W., Nganga L., Odhiambo J., and Klatser P.R. A comprehensive study of the efficiency of the routine pulmonary tuberculosis diagnostic process in Nairobi. Int J Tuberc Lung Dis 7 (2003) 186-189
14. Aluoch J.A., Swai O.B., Edwards E.A., et al. Studies of case-finding for pulmonary tuberculosis in outpatients at 4 district hospitals in Kenya. Tubercle 66 (1985) 237-249
15. Hnizdo E., Singh T., and Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax 55 (2000) 32-38
16. Fox W., Ellard G.A., and Mitchison D.A. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications. Int J Tuberc Lung Dis 3 suppl 2 (1999) S231-S279
17. World Health Organization - Stop TB Partnership. The stop TB strategy (2006).
18. Volmink J., and Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev 4 (2007 Oct 17) CD003343
19. Newell J.N., Baral S.C., Pande S.B., Bam D.S., and Malla P. Family-member DOTS and community DOTS for tuberculosis control in Nepal: cluster-randomised controlled trial. Lancet 367 (2006) 903-909
20. World Health Organization - Stop TB Partnership. Guidelines for the programmatic management of drug-resistant tuberculosis (2006).
21. Mitchison D.A., and Nunn A.J. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis 133 (1986) 423-430
22. Thwaites G.E., Chau T.T., Stepniewska K., et al. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet 360 (2002) 1287-1292
23. Thwaites G.E., Nguyen D.B., Nguyen H.D., et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 351 (2004) 1741-1751
24. Perriens J.H., St Louis M.E., Mukadi Y.B., et al. Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months. N Engl J Med 332 (1995) 779-784
25. Wiktor S.Z., Sassan-Morokro M., Grant A.D., et al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial. Lancet 353 (1999) 1469-1475
26. Shelburne III S.A., and Hamill R.J. The immune reconstitution inflammatory syndrome. AIDS Rev 5 (2003) 67-79
27. World Health Organization. WHO Report 2007. Global tuberculosis control surveillance, planning, financing (2007).
28. Godfrey-Faussett P., Sonnenberg P., et al. Tuberculosis control and molecular epidemiology in a South African gold-mining community. Lancet 356 (2000) 1066-1071